Bio-Rad Laboratories Inc.
BIO | NYSE
$362.94
-$9.24 (-2.48%)
Nov 2, 2026, 3:43 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 651M | 592.1M | 693.2M | 653M | 651.6M | 585.4M | 667.48M | 649.73M | 638.48M | 610.82M | 681.18M | 632.12M | 681.11M | 676.84M | 730.29M | 680.8M | 691.1M | 700.06M | 732.77M | 747.05M | 715.93M | 726.8M |
Cost of Revenue | 305.2M | 282.7M | 348M | 309.6M | 306.3M | 279.4M | 325.56M | 293.83M | 282.76M | 284.35M | 315.28M | 296.44M | 318.63M | 314.43M | 333.19M | 307.01M | 295.12M | 297.43M | 331.77M | 309.61M | 314.33M | 326.17M |
Gross Profit | 345.8M | 309.4M | 345.2M | 343.4M | 345.3M | 306M | 341.91M | 355.9M | 355.12M | 326.47M | 365.9M | 335.68M | 362.48M | 362.42M | 397.1M | 373.79M | 395.98M | 402.64M | 401M | 437.44M | 401.6M | 400.63M |
Operating Income | 72.6M | 34.1M | 61.9M | 66.4M | 77.1M | 23.7M | 58.33M | 64.47M | 101.5M | 52.01M | 97.79M | 90.95M | 89.62M | 61.91M | 118.67M | 92.8M | 120.22M | 146.41M | 106.98M | 156.8M | 124.78M | 100.86M |
Interest Income | 22.3M | 21M | 31M | 13.7M | 14.7M | 36.2M | 15.9M | 15.5M | 16.6M | 34M | 16.8M | 17.3M | 16.5M | 50.3M | 12.3M | 8M | 5.5M | 32.2M | 200K | -300K | 700K | 18.3M |
Pretax Income | 542.1M | -689.8M | 929.2M | -431.1M | 414M | 83.4M | -908.9M | 861.62M | -2.79B | 491.08M | 428.39M | 137.1M | -1.5B | 84.83M | 1.09B | -209.17M | -1.22B | -4.37B | -2.04B | 5.02B | 1.16B | 1.3B |
Net Income | 371.4M | -527.1M | 720M | -341.9M | 317.8M | 64M | -715.8M | 653.17M | -2.17B | 383.92M | 349.71M | 106.26M | -1.16B | 68.96M | 833.49M | -164.23M | -927.18M | -3.37B | -1.57B | 3.93B | 914.11M | 977.41M |
Selling & General & Admin | 212M | 212.4M | 216.6M | 206.8M | 207.7M | 208.8M | 204M | 200.44M | 196.12M | 210.48M | 205.9M | 201.2M | 207.82M | 225.55M | 212.23M | 211.05M | 208.73M | 196.69M | 224.15M | 216.15M | 213.43M | 225.85M |
Research & Development | 61.2M | 62.9M | 65.7M | 71.3M | 60.5M | 73.5M | 79.62M | 91M | 59.3M | 63.98M | 62.21M | 43.54M | 65.04M | 74.95M | 66.2M | 69.95M | 67.03M | 59.54M | 69.87M | 64.48M | 63.39M | 73.91M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -42K | n/a | -1.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -579K | -96K | n/a |
Operating Expenses | 273.2M | 275.3M | 282.3M | 278.1M | 268.2M | 282.3M | 283.58M | 291.44M | 253.62M | 274.46M | 268.11M | 244.73M | 272.87M | 300.5M | 278.43M | 281M | 275.76M | 256.23M | 294.02M | 280.63M | 276.82M | 299.77M |
Interest Expense | n/a | 12.3M | 12.1M | 12.3M | 12.6M | 12M | 12.19M | 12.17M | 12.26M | 12.28M | 12.36M | 12.4M | 12.34M | 12.34M | 11.68M | 11.66M | 10.72M | 4.05M | 364K | 426K | 363K | 398K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 578.4M | 558M | 630.7M | 587.7M | 574.5M | 561.7M | 609.15M | 585.26M | 538.18M | 558.81M | 583.39M | 541.18M | 591.49M | 614.93M | 611.62M | 588M | 570.88M | 553.65M | 625.79M | 590.25M | 591.15M | 625.93M |
Income Tax Expense | 170.7M | -162.7M | 209.2M | -89.2M | 96.2M | 19.4M | -193.1M | 208.45M | -620.8M | 107.16M | 78.68M | 30.85M | -338.18M | 15.87M | 263.55M | -44.94M | -295.7M | -1B | -464.4M | 1.09B | 242.66M | 319.79M |
Shares Outstanding (Basic) | 26.75M | 26.96M | 26.98M | 26.92M | 27.23M | 27.94M | 28M | 27.95M | 28.4M | 28.52M | 28.79M | 29.1M | 29.36M | 29.6M | 29.68M | 29.71M | 29.79M | 29.93M | 29.92M | 29.81M | 29.76M | 29.82M |
Shares Outstanding (Diluted) | 26.81M | 26.96M | 27.01M | 26.92M | 27.23M | 27.96M | 28M | 27.99M | 28.4M | 28.54M | 28.82M | 29.22M | 29.36M | 29.75M | 29.79M | 29.73M | 29.79M | 29.93M | 29.92M | 30.22M | 30.15M | 30.19M |
EPS (Basic) | 13.89 | -19.55 | 26.69 | -12.70 | 11.67 | 2.29 | -25.57 | 23.37 | -76.26 | 13.46 | 12.15 | 3.65 | -39.59 | 2.33 | 27.89 | -5.53 | -31.12 | -112.58 | -52.59 | 131.75 | 30.71 | 32.77 |
EPS (Diluted) | 13.85 | -19.55 | 26.65 | -12.70 | 11.67 | 2.29 | -25.57 | 23.34 | -76.26 | 13.45 | 12.14 | 3.64 | -39.59 | 2.32 | 27.78 | -5.52 | -31.12 | -112.57 | -52.59 | 129.96 | 30.32 | 32.38 |
EBITDA | 542.1M | -636.6M | 993.7M | -364.6M | 477.2M | 133.5M | -847.4M | 922.89M | -2.73B | 551.16M | 493.75M | 197.6M | -1.43B | 142.77M | 1.15B | -161.36M | -1.17B | -4.33B | -2B | 5.07B | 1.2B | 1.34B |
EBIT | 542.1M | -677.5M | 941.3M | -418.8M | 426.6M | 95.4M | -896.7M | 873.79M | -2.77B | 503.36M | 440.75M | 149.5M | -1.49B | 97.17M | 1.1B | -195.66M | -1.21B | -4.36B | -2.04B | 5.02B | 1.16B | 1.3B |
Depreciation & Amortization | n/a | 40.9M | 52.4M | 54.2M | 50.6M | 38.1M | 49.3M | 49.1M | 46.6M | 47.8M | 53M | 48.1M | 57.6M | 45.6M | 50.07M | 34.3M | 42.6M | 33.4M | 33.7M | 43.4M | 43.5M | 42.5M |
Add to Watchlist
Select watchlists to add or remove BIO